BIOA vs EVO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 14, 2026

BIOA

33.6
AI Score
VS
EVO Wins

EVO

36.4
AI Score

Investment Advisor Scores

BIOA

34score
Recommendation
AVOID NEW MONEY

EVO

36score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric BIOA EVO Winner
Forward P/E 0 19.4553 Tie
PEG Ratio 0 1.4223 Tie
Revenue Growth -85.5% 0.6% EVO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 33.6/100 36.4/100 EVO
Profit Margin 0.0% -25.2% BIOA
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

BIOA 1M: +3.7% · 3M: -46.6% EVO 1M: +11.3% · 3M: -19.4%

Current Technical Phase

BIOA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -21.7%), weak momentum, RSI 42

RSI (14): 42.3 · Price: $5.55

EVO

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -8.5%) with fading momentum, RSI 48

RSI (14): 47.9 · Price: $1.58

Fundamentals Snapshot

Metric BIOA EVO
Market Cap — —
Forward P/E -2.1 19.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.9% 0.0%
Gross Margin -10.6% 0.1%
Operating Margin -14.0% -0.2%
EPS -2.56 -0.59
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, EVO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.